Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox.
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE3
Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL
- Status
- TERMINATED
- Phase
- PHASE2
Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Azacitidine Plus Deferasirox (ICL670) in Higher Risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA
- Status
- COMPLETED
- Phase
- PHASE2
Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML
- Status
- TERMINATED
- Phase
- PHASE1
Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Part 2 Expansion of Oral Rigosertib in Combination With Azacitidine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery
- Status
- TERMINATED
- Phase
- PHASE1
Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2